In clinical trials, the most common were nausea and vomiting, fatigue, infection, loss of appetite, and blood disorders (including anemia, thrombocytopenia, and leukopenia). It has also been associated with infections, and with metabolic disturbances (such as abnormal electrolyte levels), skin reactions, altered taste perception, and changes in cardiac electrical conduction. References
External links
Clinical trials of romidepsin at ClinicalTrials.gov
In addition, the users reported that the exoskeleton did not affect their voluntary motion. These results indicate the feasibility of tremor suppression through biomechanical loading. The main drawbacks of this mechanical management of tremor are (1) the resulting bulky solutions, (2) the inefficiency in transmitting loads from the exoskeleton to the human musculo-skeletal system and (3) technological limitations in terms of actuator technologies. In this regard, current trends in this field are focused on the evaluation of the concept of biomechanical loading of tremor through selective Functional Electrical Stimulation (FES) based on a (Brain-to-Computer Interaction) BCI-driven detection of involuntary (tremor) motor activity. See also
Cerebral Palsy
Fasciculation  ("at rest" muscle twitches; usually benign). Fibrillation
Restless Leg Syndrome
Shivering
Chronic solvent-induced encephalopathy
Neurology

References
External links

"NINDS Tremor Information Page". National Institute of Neurological Disorders and Stroke. July 20, 2007. Archived from the original on October 6, 2007. Retrieved 2007-10-08. Some text copied with permission and thanks. Sigvardt, Karen A.; Wheelock, Vicki L.; Kuznetsov, Alexey S.; Rubchinsky, Leonid L. (4 October 2007). "Leonid L. Rubchinsky et al. (2007) Tremor". Scholarpedia. 2 (10): 1379. doi:10.4249/scholarpedia.1379. orthostatictremor.org